H396P mutation in chronic myeloid leukaemia patient on nilotinib - A case report von Jamali, N S, Raja Sabudin, R Z A, Alauddin, H, Ithnin, A, Tumian, N R, Jalil, N, Awai, R, Abu Amis, S H, Shuib, S

Volltext

FISH versus real-time quantitative PCR for monitoring of minimal residual disease in chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy von Haidary, A M, Azma, R Z, Ithnin, A, Alauddin, H, Tumian, N R, Tamil, A M, Razak, N F A, Abu Amis, S H, Zin, N M, Shuib, S

Volltext

H396P mutation in chronic myeloid leukaemia patient on nilotinib - A case report von Jamali, Nor Syazana, Sabudin, Raja Zahratul Azma Raja, Alauddin, Hafiza, Ithnin, Azlin, Tumian, Nor Rafeah, Jalil, Norunaluwar, Awai, Rinie, Abu Amis, Siti Hawa, Shuib, Salwati

Volltext